ESSA Pharma (EPIX) Stock Chart & Stock Price History $1.70 +0.01 (+0.59%) As of 04:00 PM Eastern Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock ESSA Pharma Stock Price Performance The ESSA Pharma (EPIX) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 67.31%, with a year-to-date return of -5.03%. In the past month, the stock has increased 1.19%, reflecting recent market activity. As of the latest close, ESSA Pharma traded at $1.69 with a market cap of $75.02 million and volume of 48,364 shares. Five years ago, the stock traded at $5.05, representing a 66.34% decrease over that period. At the time, it had a market cap of $108.50 million and a volume of 34,243 shares. Receive EPIX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for ESSA Pharma and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-0.58%1 Month Performance+1.19%3 Month Performance+2.41%Year-To-Date Performance-5.03%1 Year Performance-67.31%5 Year Performance-66.34% EPIX Stock Chart for Thursday, June, 12, 2025 EPIX Chart by TradingView ESSA Pharma Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization06/11/2025$1.71$1.69-1.17%$1.74$1.6848,364 shs$75.02 million06/10/2025$1.70$1.71+0.59%$1.72$1.7044,783 shs$75.91 million06/09/2025$1.71$1.70-0.58%$1.72$1.6978,579 shs$75.46 million06/06/2025$1.71$1.71$1.73$1.6976,303 shs$75.91 million06/05/2025$1.71$1.71$1.72$1.6955,988 shs$75.91 million06/04/2025$1.71$1.71$1.73$1.7026,428 shs$75.91 million06/03/2025$1.71$1.71$1.74$1.7039,987 shs$75.91 million06/02/2025$1.68$1.71+1.79%$1.73$1.6788,048 shs$75.91 million05/30/2025$1.67$1.68+0.60%$1.69$1.6642,382 shs$74.57 million05/29/2025$1.68$1.67-0.60%$1.70$1.6561,119 shs$74.13 million Get the Latest News and Ratings for EPIX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for ESSA Pharma and its competitors with MarketBeat's FREE daily newsletter. 05/28/2025$1.61$1.68+4.35%$1.70$1.6595,942 shs$74.57 million05/27/2025$1.69$1.61-4.73%$1.69$1.60372,214 shs$71.47 million05/26/2025$1.69$1.69$1.69$1.669,320 shs$75.02 million05/23/2025$1.66$1.69+1.81%$1.69$1.669,320 shs$75.02 million05/22/2025$1.66$1.66$1.68$1.6336,460 shs$73.69 million05/21/2025$1.65$1.66+0.61%$1.68$1.6542,286 shs$73.69 million05/20/2025$1.70$1.65-2.94%$1.71$1.63350,977 shs$73.24 million05/19/2025$1.71$1.70-0.58%$1.72$1.6862,605 shs$75.46 million05/16/2025$1.71$1.71$1.72$1.6956,474 shs$75.91 million05/15/2025$1.72$1.71-0.58%$1.72$1.6839,329 shs$75.91 million05/14/2025$1.67$1.72+2.99%$1.72$1.6723,757 shs$76.35 million05/13/2025$1.68$1.67-0.60%$1.71$1.66121,697 shs$74.13 million05/12/2025$1.72$1.68-2.33%$1.75$1.68132,962 shs$74.57 million Related Companies Olema Pharmaceuticals Stock Price Chart Canopy Growth Stock Price Chart Palvella Therapeutics Stock Price Chart Candel Therapeutics Stock Price Chart Tonix Pharmaceuticals Stock Price Chart ProKidney Stock Price Chart Annexon Stock Price Chart Neurogene Stock Price Chart Prothena Stock Price Chart Cartesian Therapeutics Stock Price Chart Receive EPIX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for ESSA Pharma and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:EPIX) was last updated on 6/12/2025 by MarketBeat.com Staff From Our PartnersTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredBig Changes Coming to Social Security?According to legendary investor Louis Navellier... This new Trump move could soon not only save Social Secu...InvestorPlace | SponsoredSHOCKING: Musk's Pentagon Secret Mission...It's about a harrowing message discovered on December 16, 2024: "美国军方暗杀名单" It's the reason President Tru...Behind the Markets | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ESSA Pharma Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ESSA Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy EPIX Stock Free EPIX Stock Alerts